Genky DrugStores Co., Ltd.
Genki Drug Stores June 2026 Fiscal Year Earnings Report ｜ Sales of 220.9 billion yen (+10.6% YoY)
Genki Drug Stores achieved sales of 220.9 billion yen (up 10.6% YoY) for the fiscal year ending June 2026, maintaining increased revenue and profit. The company plans to continue proactive store expansion and operational efficiencies.
Key Figures
- Sales: 220.9 billion yen (+10.6% YoY)
- Operating Income: 10,985 million yen (+9.2% YoY)
- Net Income: 8,785 million yen (+4.1% YoY)
AI要約
Performance Overview
Genki Drug Stores achieved sales of 220.9 billion yen (up 10.6% YoY) for the fiscal year ending June 2026, continuing its growth in revenue and profit. Operating income was 10,985 million yen (+9.2%), and net income was 8,785 million yen (+4.1%), establishing a stable earnings foundation. Through new store openings and efficiency improvements at existing stores, the company aims to enhance profitability and will continue to promote active store expansion and management efficiency measures.
Future Outlook and Strategies
The company will continue expanding store openings and renovating existing stores, reinforcing its community-oriented store network. Additionally, it will invest in IT to improve operational efficiency and expand product lineup to enhance customer satisfaction. For the full-year forecast for June 2027, sales are expected to reach 244.0 billion yen (+10.6%), with operating income of 12,000 million yen (+9.2%), aiming for sustainable growth.
Genki Drug Stores Co., Ltd.
Company overview · Stock price · Financial data · All IR
